Top 20 stocks similar to Chugai Pharmaceutical Co. Ltd based on sector, industry, market cap, and valuation multiples. Same-industry peers (Drug Manufacturers - General) are ranked first.
| Company | Market Cap | Change | Compare |
|---|---|---|---|
CHUGAI PHARMACEUTICAL CO.,LTD. 4519 • Japan | $87.52B | +2.16% | vs |
Chugai Pharmaceutical Co Ltd ADR CHGCY • United States | $88.23B | -2.27% | vs |
BA Bayer AG PK BAYRY • United States | $47.55B | +2.30% | vs |
BA Bayer AG BAYZF • United States | $48.67B | +3.49% | vs |
Bayer AG NA BAYN • Germany | $47.63B | +2.44% | vs |
DAIICHI SANKYO COMPANY,LIMITED 4568 • Japan | $35.41B | +5.93% | vs |
Sanofi SNYN • Mexico | $114.63B | -5.26% | vs |
45 Otsuka Holdings Co.,Ltd. 4578 • Japan | $30.23B | +1.33% | vs |
GSK plc GLAXF • United States | $117.82B | +0.85% | vs |
AstraZeneca PLC AZNCF • United States | $290.60B | +2.63% | vs |
GS GSK plc GS71 • Germany | $116.18B | -1.40% | vs |
AM Amgen Inc AMGN • United States | $191.53B | +1.22% | vs |
Sanofi SA SAN • France | $116.41B | +2.28% | vs |
Sanofi SNW • Germany | $116.83B | +2.39% | vs |
Astellas Pharma Inc. 4503 • Japan | $24.76B | -1.36% | vs |
AstraZeneca PLC AZN • United States | $317.50B | +0.38% | vs |
AM Amgen Inc. AMG • Germany | $190.85B | -0.05% | vs |
Gilead Sciences Inc GIS • Germany | $171.20B | -2.31% | vs |
Bristol-Myers Squibb Company BMY • United States | $122.85B | +2.64% | vs |
AstraZeneca PLC ZEG • Germany | $308.99B | +0.00% | vs |
Similarity is scored by sector match (baseline), industry match (priority boost), log-scale market cap proximity, and valuation multiple closeness (P/E and dividend yield). Same-industry peers surface first, then nearest-size same-sector peers.